In conclusion, our data establish that OPN deficiency contributes to mitigation of hypercholesteremic kidney injury as shown by downregulation of LOX-1, and suppression of foam cell formation, lipid deposition, and glomerulosclerosis. This evidence concerns the gene SPP1 and glomerulosclerosis.